Kidney Transplantation: A Pharmacist-Focused Discussion of Common Clinical Issues Related to Comorbidities, Renal Function, and Organ Rejection
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
A. Scott Mathis, PharmD
Administrative Director Pharmacy and Medication Use Pharmacy Department Monmouth Medical Center Long Branch, NJ
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.
Faculty
A. Scott Mathis, PharmD
Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD
Pharmacy Times Editorial Staff
Jennifer Whartenby and David Allikas
PTOCPE uses an anonymous peer reviewer as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Examine clinical issues and common comorbidities facing patients with kidney transplant.
- Discuss the role and mechanism of action of currently available immunosuppressive regimens used in managing patients with kidney transplant.
- Explore adverse effect and interaction profiles of currently available immunosuppressive regimens.
- Differentiate between calcineurin inhibitors and newer agents used to prevent rejection in kidney transplant patients.
- Address the pharmacist's role in counseling patients on adverse effects and interactions of currently available immunosuppressive regimens.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: January 12, 2013
Expiration date: January 12, 2015
Estimated time to complete activity: 3 hours
Fee: This lesson is free online
Click here to view this activity.
